Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Autografting

Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection

Bone Marrow Transplantation volume 35, pages 375–381 (2005)Cite this article

Summary:

Engraftment syndrome (ES) following autologous hematopoietic stem cell transplantation (AHSCT) is characterized by fever and rash. In January 2002, we instituted steroid prophylaxis for ES from day +4 to +14. This study was conducted to assess whether this practice increased the risk of infection. In total, 194 consecutive patients were reviewed, 111 did not receive steroid prophylaxis (group A), and 83 did (group B). Initial antimicrobial prophylaxis was the same in both groups. There were no significant differences between groups in age, gender, race, prior radiation therapy, number of prior chemotherapy regimens, disease status at transplant, mobilization regimen, days of leukopheresis, CD34+ cell dose, and days to platelet and neutrophil engraftment. Group B had significantly fewer patients with non-Hodgkin's lymphoma and multiple myeloma, shorter median duration from diagnosis to transplant, lower risk of ES, and shorter mean length of hospital stay. The incidence of early and late microbiologically confirmed infections was not significantly different between groups. Types of infections and types of organisms identified were similar in both groups. Hospital readmission rates were similar in both groups. Steroid prophylaxis significantly decreases the risk of ES following AHSCT, and is associated with shortened hospitalization, without increasing risk of infection.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Edenfield WJ, Moores LK, Goodwin G, Lee N . An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose. Bone Marrow Transplant 2000; 25: 405–409.

    Article  CAS  Google Scholar 

  2. Lee C-K, Gingrich RD, Hohl RJ, Ajram KA . Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 1995; 16: 175–182.

    CAS  Google Scholar 

  3. Spitzer TR . Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893–898.

    Article  CAS  Google Scholar 

  4. Ravoet C, Feremans W, Husson B et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. Bone Marrow Transplant 1996; 18: 943–947.

    CAS  Google Scholar 

  5. Akasheh M, Eastwood D, Vesole DH . Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte–macrophage colony-stimulating factor (GM-CSF). Bone Marrow Transplant 2003; 31: 113–116.

    Article  CAS  Google Scholar 

  6. Madero L, Vicent MG, Sevilla J et al. Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 2002; 30: 355–358.

    Article  CAS  Google Scholar 

  7. Maiolino A, Biasoli I, Lima J et al. Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria. Bone Marrow Transplant 2003; 31: 393–397.

    Article  CAS  Google Scholar 

  8. Oyama Y, Cohen B, Traynor A et al. Engraftment syndrome: a common cause of rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplant 2002; 29: 81–85.

    Article  CAS  Google Scholar 

  9. Khan SA, Gaa B, Pollock BH et al. Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival. Biol Blood Marrow Transplant 2001; 7: 433–438.

    Article  CAS  Google Scholar 

  10. Nash RA, Bowen JD, McSweeney PA et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood 2003; 102: 2364–2372.

    Article  CAS  Google Scholar 

  11. Braunschweig I, Mizra NQ, Rondon G et al. High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer. Cytotherapy 2000; 2: 105–110.

    Article  CAS  Google Scholar 

  12. Ericson SG, Zhao Y, Gao H et al. Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor. Blood 1998; 91: 2099–2107.

    CAS  Google Scholar 

  13. Diaz MA, Vicent MG, Prudencio M et al. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation. Haematologica 2002; 87: 292–298.

    PubMed  Google Scholar 

  14. Openshaw H, Nash RA, McSweeney PA . High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical review. Biol Blood Marrow Transplant 2002; 8: 233–248.

    Article  CAS  Google Scholar 

  15. Avery RK, Pohlman BL, Mossad SB et al. The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization. Bone Marrow Transplant 2002; 30: 311–314.

    Article  CAS  Google Scholar 

  16. Ketterer N, Espinouse D, Chomarat M et al. Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors. Am J Med 1999; 106: 191–197.

    Article  CAS  Google Scholar 

  17. Mossad SB, Longworth DL, Goormastic M et al. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 1996; 18: 265–271.

    CAS  Google Scholar 

  18. Offidani M, Corvatta L, Olivieri A et al. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplant 1999; 24: 1079–1087.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA

    S Mossad & R Avery

  2. Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH, USA

    M Kalaycio, R Sobecks, B Pohlman, S Andresen, J Jarvis & B Bolwell

  3. Department of Biostatistics and Epidemiology, Cleveland Clinic Foundation, Cleveland, OH, USA

    L Rybicki

Authors
  1. S Mossad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Kalaycio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Sobecks
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B Pohlman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Andresen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R Avery
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L Rybicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J Jarvis
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. B Bolwell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Mossad.

Additional information

This paper was presented in part at the 45th American Society of Hematology Annual Meeting, December 6–9, 2003, San Diego, CA (abstract # 3633).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mossad, S., Kalaycio, M., Sobecks, R. et al. Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection. Bone Marrow Transplant 35, 375–381 (2005). https://doi.org/10.1038/sj.bmt.1704769

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704769

Keywords

This article is cited by

Search

Advanced search

Quick links